Nuwellis Inc vs Rivian Automotive, Inc. — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while Rivian Automotive, Inc. trades at $14.31 (market cap $20.75B). The key difference: Rivian Automotive, Inc. is far larger — about 9431.8× Nuwellis Inc's market cap, and Rivian Automotive, Inc. is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Rivian Automotive, Inc. for 61 Days on average.
| NUWE | RIVN | |
|---|---|---|
Market Cap | $2.20M | $20.75B |
Volume | 121,544 | 26,144,654 |
Sector | Health | Consumer Cyclical |
52-Week High | $146.65 | $22.45 |
52-Week Low | $0.68 | $12.50 |
Typical Hold Time | 26 Days | 61 Days |
Enterprise Value | -$1.52M | $20.79B |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Rivian Automotive (RIVN) trades at $14.34, down 1.17% on the day, reflecting a bearish technical outlook despite recent record Q3 2026 deliveries of 19,248 vehicles. The company continues to post significant net losses, with a -54.95% net income margin for 2025, though revenue growth is evident, rising to $5.39B. Analyst consensus is mixed, with a $16.89 price target, but cash burn remains a concern with negative operating cash flow.
The outlook hinges on R2 production scaling and future profitability; upside exists if Rivian achieves cost reductions and autonomy tech gains traction, but high cash burn, competitive pressures, and execution risks pose substantial threats to shareholder value in the near term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →